Photo from cancer.gov
Jul 8, 2024, 04:52
Spotlight on Alveolar soft part sarcoma – NCI
National Cancer Institute (NCI) shared a post on LinkedIn:
“Alveolar soft part sarcoma (ASPS) is a rare, slow-growing cancer that starts in soft tissues and affects mostly adolescents and young adults. ASPS does not respond to chemotherapy, and when patients’ tumors cannot be removed surgically, it has been difficult to treat.
Many patients with ASPS are referred to the NIH Clinical Center (CC), where a clinical trial led to the first FDA-approved treatment of the drug atezolizumab for advanced cases of the cancer. Read more.”
Source: NCI/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12